Baligasa, Normia O.
HRN: 21-41-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2022
CEFUROXIME 500MG (TAB)
06/01/2022
06/07/2022
ORAL
1 Tab BID
7 Days
Urinary Tract Infection
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes